Aim: Takotsubo syndrome (TTS) patients have a higher mortality rate than the general population. Our study was conducted to determine the short-and long-term outcome of TTS patients associated with a significantly compromised mitral annular plane systolic excursion (MAPSE) on hospital admission. Methods and results: Our institutional database constituted a collective of 53 patients diagnosed with TTS between 2003 and 2016. The patients were classified into two groups based on the MAPSE, with those presenting with an MAPSE <1 cm on admission categorized into one group (n ¼ 20, 38%) and those presenting with MAPSE 1 cm (n ¼ 33, 62%) categorized into another group. Preliminary results indicated that patients with an MAPSE < 1 cm had a greater risk of developing thromboembolic events. The long-term mortality was significantly higher in TTS patients with an MAPSE < 1 cm. In the multivariate Cox regression analysis, cardiogenic shock (hazard ratio 3.5; 95% confidence interval: 1.2-10.7; P ¼ 0.02) and MAPSE < 1 cm (hazard ratio 5.1; 95% confidence interval: 1.3-19.2; P ¼ 0.01) figured as independent predictors of the mortality. Conclusion: Although the short-term mortality rates among TTS patients diagnosed with a reduced MAPSE on admission were as similar as without reduced MAPSE, the long-term mortality rates among TTS patients diagnosed with a reduced MAPSE on admission were significantly higher. There is an urgent need for randomized trials, which could help define uniform clinical management strategies for high-risk TTS patients.
Introduction
Takotsubo syndrome (TTS) was first described in 1990. It is a transient reversible disorder of ventricular wall dysfunction clinically representative of an acute heart failure with substantial risk for adverse events [1] [2] [3] trigerred by emotional or physical stress. 4, 5 An early classification system based on the ballooning pattern of ventricular walls, as diagnosed by transthoracic echocardiography and left ventricular (LV) angiography, enables us to sort patients into specific groups. 4 The apical form of presentation is the most common (81.7%) followed by the midventricular form (14.6%), basal (2.2%) and focal form (1.5%). The exact pathophysiological mechanism for selective wall-motion abnormality in the absence of significant coronary artery stenosis remains unknown. TTS patients present initially with symptoms such as chest pain and dyspnea, mimicking an acute coronary syndrome (ACS), however, they may also present in some cases with some critical complications such as heart failure, life-threatening arrhythmias, atrial fibrillation, acquired long QTs, thromboembolic events, recurrent TTS, LV outflow obstruction, mitral valve regurgitation or cardiac rupture. 2, 4, [6] [7] [8] [9] [10] Recently, published data have confirmed that the prognosis of TTS is not always favorable and that the mortality rates are similar to coronary artery disease. 4, [11] [12] [13] Additionally, a highly reduced ejection fraction (EF) has been proposed to be a predictor of poorer outcomes in these patients. This predictive relationship could theoretically also be extended to mitral annular plane systolic excursion (MAPSE), a parameter indicative of LV function. 13 The present study was conducted to determine the short-and long-term outcomes and prognostic impact of a reduced MAPSE in TTS patients.
Methods
All relevant data derived from the 53 patients with TTS in our institution between January 2003 and September 2016 were subjected to an in-depth analysis. The patients were diagnosed according to the Mayo Clinic Criteria, 14 which outlines the clinical features associated with TTS. These criteria essentially highlight the transient wall motion abnormality in the LV mid-segments with or without apical involvement; mention regional wall motion abnormalities that extend beyond a single epicardial vascular distribution; and describe an event that occurs frequently, but not always in the wake of a successful trigger. Additionally, these criteria mandate the effective rule-out of obstructive coronary disease; focuses on the appearance of new ECG pathologies, which mimic ACS or modest elevations in cardiac troponin levels; and underlines the prerequisite absence of diseases like pheochromocytoma and myocarditis in the patient.
Based on large prospectively clinical studies showing that the reduced lateral MAPSE <1 mm is an independent predictor of adverse outcome and the septal MAPSE is more affected by right ventricular involvement, 15 we aimed to study the prognostic impact of lateral MAPSE in our TTS patients. Patients were primarily classified into two groups defined by MAPSE values greater or lesser than 1 cm, as assessed at the time of hospital admission by echocardiography in the apical 4 chamber view. The angiograms, echocardiograms and ECGs establishing the diagnosis of TTS were reviewed by two experienced independent cardiologists. This study was conducted in compliance with the Declaration of Helsinki regarding investigations in human subjects and the study protocol was approved by the Ethics Committee of University Medical Centre Mannheim.
In-hospital events, arrhythmias, cardiac rupture, thromboembolic events, pulmonary congestion with the use of noninvasive positive-pressure ventilation, endotracheal intubation, use of a temporary pacemaker, use of inotropic agents, and inhospital death were assessed based on chart review. The primary end-point of our study was all-cause of mortality as assessed by chart review and/or telephonic review. If medical records, treating physicians or relatives were unable to substantiate information identifying the circumstances of death, it was defined as death due to an unknown cause.
Statistics
The data are presented as means 6 standard deviation for continuous variables with a normal distribution, median (interquartile range) for continuous variables with a non-normal distribution, and as frequency (%) for categorical variables.
The Kolmogorov-Smirnov test was used to assess normal distribution. Student's t-test and the Mann-Whitney U-test were used to compare continuous variables with normal and nonnormal distributions, respectively. The v 2 -test or Fisher's exact test was used to compare categorical variables. The log-rank test was used to compare the survival curves between the TTS group with MAPSE 1 cm and the TTS group with MAPSE 1 cm. Factors with P < 0.10 in the univariate analysis were entered in to the Cox multivariate regression to define independent risk factors for the end-point. Statistical analysis was performed with SPSS in all analyses, P 0.05 (two-tailed) was taken to indicate statistical significance.
Results

Baseline demographics
We studied the clinical and echocardiographic data of 53 TTS patients with a mean follow-up of 1529 6 1121 days. The patients were classified into two groups according to the presenting MAPSE, of either greater than 1 cm (n ¼ 33, 62%) or lesser than 1 cm (n ¼ 20, 38%) at admission. The baseline demographics demonstrated a predominance of postmenopausal females in both groups and this is duly represented in Table 1 . A detailed comparison of the two TTS case groups further suggested that patients diagnosed with an MAPSE 1 cm often represented a population subgroup with high body-mass-index (BMI) values (BMI 25 kg/m 2 ). Additionally the diastolic blood pressure was significantly lower in the group with MAPSE < 1 cm. Patients with MAPSE < 1 cm showed a highly reduced EF as compared to those with MAPSE 1 cm. The treatment protocol constituting b-blocker drugs, statins, aspirin and some form of therapeutic anticoagulation on admission as well as on discharge was similar in both groups. A follow-up echocardiography after 6 months showed almost similarly normal LV-EF values in both patient groups (50.6 6 12.1% vs. 56.1 6 8.6%; P > 0.05).
In-hospital events and treatment course
The incidence of cardiogenic shock complicating the course of TTS in these patients was similar in both groups (15% vs. 15%; P > 0.05). Although, life-threatening arrhythmias and mechanical respiratory support had to be initiated more often in those patients with an MAPSE < 1 cm as compared to those with an MAPSE 1 cm, this difference did not achieve any statistical significance, Table 1 . Furthermore, the in-hospital mortality and 30-day mortality were similar in both groups (6% vs. 10%). Interestingly, TTS patients with an MAPSE < 1 cm suffered thromboembolic events (9% vs. 20%; P ¼ 0.06) more often than the other group of patients.
Long-term outcome
Patients with an MAPSE < 1 cm showed an increased risk of death beyond the first 30-days after admission resulting in a considerably elevated 1-year mortality rate (30% vs. 6.0%; P < 0.05). Long-term mortality rate was 65% in TTS patients with MAPSE < 1 cm and 18% in TTS patients with MAPSE > 1 cm; P < 0.01; Table 2 and Figure 1) . A Kaplan-Meier analysis confirmed the ongoing long-term mortality in TTS patients with MAPSE < 1 cm. The cardiac cause of death in MAPSE < 1 cm was (n ¼ 1; sudden cardiac death, n ¼ 1; respiratory failure due to cardiac failure and n ¼ 1; cardiogenic shock) as compared to MAPSE > 1 cm (n ¼ 1; respiratory failure due to cardiac failure and n ¼ 1; cardiogenic shock). The non-cardiac cause of death Bold value mean significant P<0.05 was in MAPSE < 1 cm (n ¼ 1; intracranial bleeding, n ¼ 1; sepsis, n ¼ 1; pulmonary failure due to chronic obstructive pulmonary disease (COPD), n ¼ 4; advanced cancer, n ¼ 1; kidney failure) as compared to MAPSE > 1 cm (n ¼ 2; advanced cancer, n ¼ 1; kidney failure). One case with unknown cause of death was noticed in MAPSE > 1 cm as compared with two cases in MAPS < 1 cm. Cardiovascular and non-cardiovascular cause of death was similar in both groups. In the Cox univariate analysis, male gender (P < 0.01), EF 35% (P < 0.01), cardiogenic shock (P < 0.01), MAPSE < 1 cm (P < 0.01) and hypertension (P ¼ 0.07) were associated with the primary end-point. In the multivariate Cox regression analysis, cardiogenic shock (hazard ratio (HR) 3.5; 95% confidence interval (CI): 1.2-10.7; P ¼ 0.02) and MAPSE < 1 cm (HR 5.1; 95% CI: 1.3-19.2; P ¼ 0.01) figured as independent predictors of the mortality (Table 3) .
Discussion
TTS was initially thought to be a transient disorder of the heart with a relatively good prognosis. Recent studies confirm that the mortality rate among TTS patients ranges between 1% and 8%; similar to the mortality rate of patients suffering from an ACS. 4, 7, [16] [17] [18] Trends in the short-and long-term outcome of TTS have also shown that life-threatening arrhythmias, cardiogenic shock and old age correlate with a higher mortality rate.
4,7-9,16-18
The incidence of cardiogenic shock in TTS is up to 12.4%. 3, 7, [19] [20] [21] [22] A lower LVEF has been identified as an independent predictor of cardiogenic shock with higher mortality rates among TTS patients. 21, 23 Additionally, it has been reported that biventricular TTS is more associated with cardiogenic shock than LV TTS. 24 MAPSE is a predictor of LV long axis function and plays a fundamental role in cardiac mechanics. It has been reported that an MAPSE > 1 cm is indicative of a normal cardiac function. MAPSE measured using echocardiography has also been shown to be a predictor of adverse cardiovascular outcomes in a number of conditions, including atrial fibrillation, post-myocardial infarction, heart failure and tetralogy of Fallot. [25] [26] [27] [28] Additionally, it has been reported that reduced long axis function assessed with lateral MAPSE during cine-CMR is an independent predictor of cardiovascular events. 15 Our study, the first in published medical literature, documents and compares the in-hospital complications as well as elucidates the short-and long-term prognosis of a reduced MAPSE in TTS patients.
Having conducted this retrospective single center-based clinical investigation with the cumulative experience of 53 TTS patients, we could determine that (i) the reduced MAPSE does not impact the short outcome of TTS patients; (ii) the long-term prognosis was compromised in these patients; and (iii) reduced MAPSE and cardiogenic shock could be independent predictors for the long-term mortality in TTS.
This study primarily addresses the role of echocardiography in evaluating the short-and long-term outcome of TTS. Patients with reduced MAPSE at admission demonstrated increased inhospital complications such as cardiopulmonary failure and thromboembolic events. These thromboembolic events have been described in TTS in up to 12% of cases and are attributed mainly to LV thrombus formation. In certain instances, thromboembolic events such as stroke have also been reported in the absence of thrombus formation. 29, 30 The underlying mechanism to this observation is yet to be convincingly explained. 9 A correlation between EF and thromboembolic rates in TTS is also yet to be established; 31 however, in our cohort, a reduced MAPSE correlated with reduced LVEF and higher rate of thromboembolic events. Bold value mean significant P<0.05 Figure 1 . Kaplan-Meier curve shows lower survival rate of TTS patients in presence of highly reduced MAPSE at admission over 5-year follow-up. Another interesting aspect is the fact that TTS patients with decreased MAPSE have a higher long-term mortality over 5 years. It has been reported in the literature that LVEF, reversible moderate to severe mitral regurgitation, E/e 00 ratio, and age >75 years are independent correlates to acute heart failure, cardiogenic shock and in-hospital mortality in TTS patients. 32 
Conclusion
MAPSE is a relevant prognostic parameter in TTS and may help to guide treatment strategy in TTS patients.
Study limitations
Our study had some limitations; first, this was a single-centre observational study admitting patients diagnosed over a period of 14 years and the results cannot be necessarily generalized to the larger population of patients seen in the community. Analysis of further echocardiographic criteria such as threedimensional echocardiography or two-dimensional speckle tracking was not performed. In this study, we retrospectively chose to look only at lateral MAPSE. However, in given results it would be interesting for future multicenter studies to examine the relative prognostic significance of anterior and inferior MAPSE.
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